It's important to teach children healthy screen time habits from a young age, which they can carry into adolescence and adulthood. Find out how to keep your child safe online and help them balance screen time with other activities: https://t.co/5tOFNPFx3c #HealthyHabits#Screens
🏳️🌈 Pride Month Reminder: Protect Your Health, Protect Your Community
This #PrideMonth, we celebrate love, identity and the power of showing up for ourselves and one another — and that includes our health. 🩺
🔗 https://t.co/NhUM8WbB5k
#Pride2026
The day started with breakfast & a shared vision: improving health through food. This morning, Community Health Center advocates joined #FIMCON2026 attendees in DC where NACHC CEO @KyuRheeMD highlighted the vital role CHCs play in advancing #FoodForHealth nationwide.
#ValueCHCs
A heart attack can’t be stopped once it starts — but quick action can save a life. 🫀⚡ Call 911 immediately. Early action improves survival.
Learn why every second counts: https://t.co/DEfD1h7Vat
#CPRAwarenessWeek#CPRSavesLives#HeartHealth https://t.co/PDHeJ8OI8k
“In a study published Wednesday in the American Journal of Public Health, the group of people who reported eating the highest amount of ultraprocessed foods had a 58% higher risk of later developing dementia.”
Lifestyle can impact brain health 🧠 https://t.co/a7Tnr5KgpH
BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal
84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.
Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.
The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.
A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.
Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.
At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)
Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.
Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.
This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.
With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.
In the meantime, many cancer patients are exercising their right to try.
@twc_health@McCulloughFund@IIAR_Journals@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly@FosterCoulson
Join us for a 30-minute briefing on Thursday, June 4, featuring International Medical Corps’ on-the-ground experts leading our response to the ongoing Ebola outbreak in Central Africa. Info & Registration >
https://t.co/2Xkc3ht3kf
Healthy life line: Pray with thanks for good health and wellness. Prayer Can Help You Heal & Stay Well https://t.co/Dq9JFXv8RY https://t.co/pDHjZHQeXY #health#wellness
Brain Health Awareness Month starts Monday.
Most people diagnosed with early-onset Alzheimer's are handed statistics.
Sean Terwilliger wanted a playbook instead. So he wrote one.
ALZ Fired Up! covers what most books on this topic don't: navigating a broken healthcare system, pursuing cutting-edge approaches, and choosing to live fully rather than wait.
Written by a patient for patients, caregivers, and the clinicians who support them.
Coming August 2026. https://t.co/AVLLCpKg6d
Sean is a BEACON40® brand ambassador.
June is Alzheimer's and Brain Awareness Month.
An occasion to showcase our effort to address the lack of understanding and knowledge about brain health and Alzheimer’s.
It is never too early, never too late to take charge of our brain health!
#praticolab#drdomenicopratico
As we enter Alzheimer’s and Brain Awareness Month, keep women’s brain health at the forefront. Join AMWA member Neelum T. Aggarwal, MD, and Leah Fisher for a conversation hosted by @unbiasedscience on early Alzheimer’s, diagnosis, lived experience, and early detection: https://t.co/WEHTNFY1j0
NutriNet-Santé: Exposure to preservative food additives widely used in industrial foods was associated with a higher incidence of #hypertension or #CVD.
Read the journal scan for more 👉 https://t.co/a9AgXCbg29 #cvPrev
💬 Viewpoint: #AI yields higher empathy scores in text assessments but cannot perform clinical examination or patient care. Clinician oversight and presence remain essential in #Medicine.
https://t.co/ZL1U4RcjAh
👑 𝑻𝒉𝒆 𝑺𝒖𝒈𝒂𝒓 𝑸𝒖𝒆𝒆𝒏𝒔 𝒓𝒆𝒕𝒖𝒓𝒏 𝒇𝒐𝒓 𝒔𝒆𝒂𝒔𝒐𝒏 3 𝒐𝒏 𝑱𝒖𝒏𝒆 8, 𝒍𝒊𝒗𝒆 𝒇𝒓𝒐𝒎 𝒕𝒉𝒆 𝑨𝑫𝑨!
💕 Access the CGM clinical pearls you won’t get anywhere else. And find out why the Queens always say, CGM is a right, not a privilege!
ICYMI a recent large-scale study found that drinking 2-3 cups of coffee per day is associated with a lower risk of mood and stress disorders. Read more this #MentalHealthAwarenessMonth here: https://t.co/fdgkZxTcp8